- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03934398
Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth
June 21, 2022 updated by: Johns Hopkins University
The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure.
The investigators will also investigate for predictors of vascular function and determine if predictors vary by level of sodium intake.
Study Overview
Status
Completed
Conditions
Detailed Description
This research is being done to determine if the food or salt eaten can cause arteries to be stiffer and/or not work as well and if it can impact blood pressure over a 24-hour period of time.
The investigators also want to determine if there are any risk factors or blood tests that can predict how stiff arteries are or how well arteries function.
The investigators hope that the information from this study will help the investigators prevent blood pressure-related cardiovascular disease in children.
This knowledge could help shape future guidelines on how to best prevent and treat high blood pressure and heart disease in children.
Study Type
Observational
Enrollment (Actual)
41
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins School of Medicine Division of Pediatric Nephrology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 22 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children and young adults up to 22 years of age who have overweight or obesity and elevated blood pressure, and were referred to the ReNEW Clinic for evaluation and treatment of elevated blood pressure.
Description
Inclusion Criteria:
- Overweight or obese
- Elevated blood pressure
- Referred to the ReNEW Clinic at Johns Hopkins University for evaluation and treatment of elevated blood pressure.
Exclusion Criteria:
- The only children who will not be eligible for inclusion in this study are those who are non-English speaking.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ReNEW Clinical Cohort
Individuals evaluated in the ReNEW Clinic at Johns Hopkins University who join the ReNEW Clinic Cohort Study are eligible for this cross-sectional study.
Tests will be done for all participants which includes Cardiovascular Assessments, Actigraphy and Laboratory assessments.
|
Participants will undergo the following cardiovascular assessments: 24-hour blood pressure monitoring, arterial stiffness measurements, endothelial function measurements.
Participants will wear an actigraph device for 7 days to measure participant's activity and sleep.
Participants will provide blood and urine samples for laboratory assessments.
Participants and parents will fill out questionnaires for emotional/behavioral assessments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial stiffness as assessed by Pulse wave velocity
Time Frame: 1 day
|
This will be determined from Pulse wave velocity (m/sec) done at the study visit
|
1 day
|
Arterial stiffness as assessed by Ambulatory Arterial Stiffness Index (AASI)
Time Frame: 1 day
|
The Ambulatory Arterial Stiffness Index will be determined from data obtained from vascular measures and during 24-hour ambulatory blood pressure monitoring.
Arterial stiffness increases as the regression slope approaches 0 and the AASI approaches 1.
|
1 day
|
Arterial stiffness as assessed by Augmentation Index
Time Frame: 1 day
|
The Augmentation Index (measured as a percentage) will be determined from a vascular assessment and data obtained during 24-hour ambulatory blood pressure monitoring.
A greater Augmentation Index represents a stiffer, less compliant vessel.
|
1 day
|
Endothelial function as assessed by Laser Doppler flow perfusion
Time Frame: 1 day
|
The percent change in mean blood flow will be determined from Laser Doppler flow perfusion measurements obtained using a heating protocol.
|
1 day
|
Mean Blood pressure (mmHg)
Time Frame: 1 day
|
Mean daytime systolic blood pressure in millimeters of mercury (mmHg) will be determined from 24-hour blood pressure monitoring.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pediatric Adverse Childhood Events (ACEs) score
Time Frame: 1 day
|
The Pediatric ACEs questionnaire contains 17 yes or no questions about stressful or traumatic life events.
Greater exposure to adverse childhood experiences (ACEs) is associated with poorer physical and mental health.
Some researchers have suggested that an ACEs score of greater than or equal to 3 or 4 significantly increases the risk for health problems, however, there is no widely accepted threshold for how many ACEs endorsed is clinically significant or more predictive of these problems.
|
1 day
|
Children's Emotion Management Scale (CEMS) score
Time Frame: 1 day
|
The Children's Emotional management scale is a questionnaire that consists of 33 questions (3 point Likert scale) examining youth's ability to regulate appropriately their negative emotions (i.e.
anger, sadness, and worry).
Generally, poorer emotion regulation capabilities are associated with poorer health outcomes, with most research looking at CV outcomes in adults.
|
1 day
|
Behavior Assessment for Children (BASC) score
Time Frame: 1 day
|
The Behavior Assessment for Children is a questionnaire that consists of 189 questions (True/False and 4 point Likert scale).
It is a broad behavioral screening measure commonly used in child and adolescent psychology and psychiatric settings.It has three primary scales: internalizing (e.g., depression, anxiety), externalizing (e.g., aggression, hyperactivity), and total problems (combination of internalizing and externalizing plus attention problems and withdrawal subscales).
Scores between 60-69 are considered "at risk" for clinical problems and scores of 70+ are considered clinically significant presence of those symptoms.
Any scores that are not in this range are considered to be within normal limits and not indicative of difficulties.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tammy M Brady, M.D., PhD., Johns Hopkins University Division of Pediatric Nephrology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2019
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
April 29, 2019
First Submitted That Met QC Criteria
April 29, 2019
First Posted (Actual)
May 1, 2019
Study Record Updates
Last Update Posted (Actual)
June 22, 2022
Last Update Submitted That Met QC Criteria
June 21, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00196923
- 1R56HL139620 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Cardiovascular Assessments
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedMood Disorders | Hypertension | Sleep | Overweight and Obesity | Vascular Stiffness | Elevated Blood PressureUnited States
-
Institut National de la Santé Et de la Recherche...University College, LondonCompletedHuntington Disease | White Matter AlterationsFrance
-
National Heart Centre SingaporeSingapore National Eye CentreUnknownMicroalbuminuria | Diastolic Dysfunction | Retinopathy, DiabeticSingapore
-
Swiss Tropical & Public Health InstituteWorld BankActive, not recruitingCompliant Behavior | Morbidity;InfantSwitzerland, Congo, The Democratic Republic of the
-
University Health Network, TorontoRecruiting
-
Bioray LaboratoriesXiangya Hospital of Central South University; The 923rd Hospital of Joint Logistics...Recruiting
-
Hacettepe UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount SinaiActive, not recruitingLow Risk Prostate CancerUnited States
-
BiogenCompletedFrontotemporal Dementia | Behavioral Variant Frontotemporal DementiaUnited States
-
Dokuz Eylul UniversityRecruitingRestless Legs Syndrome | Neuromyelitis OpticaTurkey